PGNX - Progenics Pharmaceuticals Inc. (PGNX) CEO Mark Baker on Q2 2019 Results - Earnings Call Transcript
Progenics Pharmaceuticals, Inc. (PGNX)
Q2 2019 Results Earnings Conference Call
August 9, 2019 08:30 AM ET
Company Participants
Melissa Downs - Head of Investor Relations
Mark Baker - Chief Executive Officer
Asha Das - Chief Medical Officer
Bryce Tenbarge - Senior Vice President, Commercial
Pat Fabbio - Executive Vice President and Chief Financial Officer
Conference Call Participants
Chad Messer - Needham & Company
Biren Amin - Jefferies
Presentation
Operator
Good day, ladies and gentlemen, and welcome to the Progenics Pharmaceuticals Second Quarter 2019 Results Conference Call. At this time, all participants are in a listen-only